![](https://media.springernature.com/w110h61/springer-static/image/art%3A10.1007%2Fs10557-011-6298-4/MediaObjects/10557_2011_6298_Fig1_HTML.gif?as=webp)
![](https://media.springernature.com/w90/springer-static/cover/journal/10557/25/1S.jpg?as=webp)
Volume 25, Issue 1 supplement
December 2011An Arginine-Vasopressin V2 receptor Antagonist, Tolvaptan, for Treatment of Heart Failure with Volume Overload - Evidence from Nonclinical Studies to Clinical Trials
- Issue Editor:
-
- Masatsugu Hori
11 articles in this issue